Leaderboard

En | De
No articles selected!     View Cart  
You are here: Respiratory Tract » Neoplasms 18. January 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Allergic Rhinitis - Hay Fever
Asthma
Bronchitis
COPD
Interstitial Lung Diseases
Pulmonary Embolism
Neoplasms
Pleural Diseases
Pneumonia
SARS
Sleep Apnoe Disorder
Tuberculosis
Cystic Fibrosis
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 7827  Previews Next
   
   Articles 1 - 20 / 156531  
   
Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancer.
J Transl Med
Cavaliere S, Fogolari M, Iuliani M, Foderaro S, Cortellini A, Simonetti S, Mingo EC, Calagna S, Russano M, Vincenzi B, Tonini G, Angeletti S, Pantano F.
PMID: 41547827 [PubMed - as supplied by publisher]


PM2.5-modulated targets and miRNAs associated with lung cancer and injury are protected by natural products.
Environ Pollut
Chuang YT, Yen CY, Liu W, Chang FR, Tsai YH, Chan WH, Chien TM, Chang HW.
PMID: 41547393 [PubMed - as supplied by publisher]


Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark.
Eur J Cancer
Budolfsen T, Petersen RH, Mřller LB, Brabrand J, Saghir Z, Quist M.
PMID: 41547178 [PubMed - as supplied by publisher]


Corrigendum to "Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial" [Radiother. Oncol. 208 (2025) 110907].
Radiother Oncol
Dejonckheere CS, Nour Y, Sahlmann J, Engelhart MT, Hammi A, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Waller C, Schmid S, Miederer M, Brose A, Binder H, König J, Rimner A, Grosu AL, Nestle U, Gkika E.
PMID: 41547133 [PubMed - as supplied by publisher]


Efficacy of levosalbutamol for lung cancer patients receiving postoperative sputum expectoration by high-frequency chest wall oscillation.
Pak J Pharm Sci
Wang Y, Leng H.
PMID: 41546583 [PubMed - indexed for MEDLINE]


Improving aerobic capacity in patients with advanced non-small cell lung cancer: study protocol of the 3-armed randomized controlled BREATH trial.
Trials
De Lazzari N, Wiesweg M, Götte M, Franco J, Mincu RI, Jäger J, Huessler EM, Kuklik N, Stang A, Totzeck M, Tewes M.
PMID: 41546104 [PubMed - as supplied by publisher]


Evaluating the efficacy and safety of antibody-drug conjugates in non-small cell lung cancer: a systematic review and meta-analysis.
BMC Cancer
Zhang L, Jia H, Niu B.
PMID: 41545863 [PubMed - as supplied by publisher]


Robotic-assisted thoracic surgery for resectable lung cancer: efficacy, safety and surgical approaches - an umbrella review of meta-analyses.
BMC Surg
Xu Y, Han Q, Wang C, Xu J, Li X, Zhang Q.
PMID: 41545856 [PubMed - as supplied by publisher]


Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial.
Signal Transduct Target Ther
Wang M, Liu W, Guo H, Long H, Yu B, Zhao G, Wu J, Yue D, Zhao X, Li C, Zhang L, Wang S, Zhang Q, Zhang Z, Wang C.
PMID: 41545337 [PubMed - indexed for MEDLINE]


Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.
J Immunother Cancer
Onieva JL, Pérez-Ruiz E, Figueroa-Ortiz LC, Jurado JM, Martínez B, Carlos Benítez J, Rueda-Domínguez A, Barragán I.
PMID: 41545302 [PubMed - indexed for MEDLINE]


Next-generation lung-cancer-on-a-chip: toward personalized therapy, AI, and CRISPR-driven models.
Drug Discov Today
Hossain NS, Tasnim N, Ferdoush J, Roy A, Saha SC, Saha A.
PMID: 41544897 [PubMed - as supplied by publisher]


Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy.
Int J Radiat Oncol Biol Phys
Zhai T, Toprani SM, Dillon-Martin M, Doyle PF, Kang H, Novack C, Liang L, Christiani DC, Kozono DE, Nagel ZD.
PMID: 41544677 [PubMed - as supplied by publisher]


Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
Lu S, Wang J, Yang N, Lv D, Chen L, Wu L, Li X, Sun L, Yu Y, Jin B, Yang L, Guo Y, Xu H, Yi T, Zeng A, Dong X, Chen J, Wang Z, Niu H, Cheng Y, Pan P, Deng P, Pan H, Min X, Bai J, Liu L, Zhang T, Li J, Fan S, Shi MM, Mok T, Su W, SACHI Study Group.
PMID: 41544643 [PubMed - as supplied by publisher]


Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib.
Clin Lung Cancer
Tomasini P, Juan-Vidal O, Califano R, Lin CC, Hulo P, Dooms C, Fang J, Blasco A, Kowalski D, Salinas J, Babu G, Mun TL, Bearz A, Surmont V, Baldotto C, Sharma R, Arrieta O, Stencel K, Card C, Zer A, Massarelli E, Fang B, Mashru S, Schuchard J, Sermon J, Diels J, Chu PL, Withelder M, Bauml JM, Shah S, Baig M, Felip E.
PMID: 41544603 [PubMed - as supplied by publisher]


Adaptive and migration-enhanced tree seed algorithm for multi-threshold CT image segmentation and lung cancer recognition.
PLoS One
Li C, Jiang J, Ma Z, Yu Z, Li H, Liu J, Li L, Yu Z.
PMID: 41544119 [PubMed - indexed for MEDLINE]


Immunotherapy after EGFR‑TKI treatment in advanced non‑small cell lung cancer: Current status and future perspectives (Review)

.

Oncol Rep
Ma H, Li L, Jiao C, Cheng Y, He J, Jiang C, Tong Q, Yi D, Zhang Y.
PMID: 41543165 [PubMed - indexed for MEDLINE]


Letter to the Editor: Association Between Immunotherapy and Overall Survival in Malnourished Patients with Advanced Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan.
Nutr Cancer
Li N, Chen H, Wang Y, Li X.
PMID: 41542856 [PubMed - as supplied by publisher]


Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report.
Cancer Rep (Hoboken)
Nigi A, Kumasa T, Iwamoto K, Itani H, Kondou S, Uraki J.
PMID: 41542718 [PubMed - indexed for MEDLINE]


General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancer.
J Liq Biopsy
Lo D, Wong J, Keenan R, Fingleton J, Wong ANM.
PMID: 41541744 [PubMed]


Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer.
iScience
Zhu L, Jia X, Xu L, Chen L, Fu X, Yan H, Ai B, Peng S.
PMID: 41541668 [PubMed]


   
   Articles 1 - 20 / 156531    Page 1 of 7827  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1